Clinical Trial Update: Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis [Phase 4]

View source ↗

Summary

A Phase 4 study comparing patient dosing preferences for ibandronate and risedronate in Korean women with postmenopausal osteoporosis has completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Actonel (risedronate)
• Boniva (ibandronate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED | Results posted: 2018-06-06